Lorcaserin Extended-Release Tablets and Zoledronic acid
Determining the interaction of Lorcaserin Extended-Release Tablets and Zoledronic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Zoledronic Acid (Bone Health)
- Lorcaserin Extended-Release Tablets-Zoledronic Acid (Zometa)
- Lorcaserin Extended-Release Tablets-Zoledronic Acid Injection
- Lorcaserin Extended-Release Tablets-Zoledronic Acid Injection Concentrate
- Lorcaserin Extended-Release Tablets-Zoledronic acid Intravenous
- Lorcaserin Extended-Release Tablets-Zoledronic Acid IV
- Zoledronic acid-Lorcaserin Hydrochloride
- Zoledronic acid-Lorcaserin Tablets
- Zoledronic acid-Lorcet
- Zoledronic acid-Lorcet Plus
- Zoledronic acid-Lorcet Tablets
- Zoledronic acid-Lorlatinib